QUEST DIAGNOSTICS INC News

company, DGX

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

see more

QUEST DIAGNOSTICS INC Market News

21h

Quest Diagnostics Surges: MRD Test, Dividend Boost

  • Quest Diagnostics (DGX) posted strong Q4 results, introduced a blood-based MRD test for multiple myeloma, and announced a meaningful dividend increase plus a $1 billion buyback authorization. These concrete developments strengthen DGX’s growth and shareholder-return thesis, while Medicare reimbursement pressure and ongoing IT modernization remain key operational factors to monitor.
CTA-image

1w 1m 6m 1Y Max